Stephen G Kaler Selected Research

Copper-Transporting ATPases

1/2020	Early-onset Wilson disease caused by ATP7B exon skipping associated with intronic variant.
1/2016	Microbial peptide de-coppers mitochondria: implications for Wilson disease.
1/2013	Catecholamine metabolites affected by the copper-dependent enzyme dopamine-beta-hydroxylase provide sensitive biomarkers for early diagnosis of menkes disease and viral-mediated ATP7A gene therapy.
11/2012	Cervical spine anomalies in Menkes disease: a radiologic finding potentially confused with child abuse.
9/2012	In utero copper treatment for Menkes disease associated with a severe ATP7A mutation.
10/2010	Molecular correlates of epilepsy in early diagnosed and treated Menkes disease.
8/2009	Relative efficiencies of plasma catechol levels and ratios for neonatal diagnosis of menkes disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stephen G Kaler Research Topics

Disease

32	Menkes Kinky Hair Syndrome (Menkes Disease) 09/2020 - 01/2002
11	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2018 - 08/2005
6	Occipital horn syndrome 05/2015 - 01/2002
5	Hepatolenticular Degeneration (Wilson's Disease) 01/2020 - 01/2012
2	dopamine beta hydroxylase deficiency 02/2013 - 02/2003
2	Neurodevelopmental Disorders 10/2010 - 08/2009
1	Neoplasms (Cancer) 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Pruritus (Itching) 12/2017
1	Dermatitis 12/2017
1	Starvation 12/2017
1	Alzheimer Disease (Alzheimer's Disease) 01/2015
1	Parkinson Disease (Parkinson's Disease) 01/2015
1	Body Weight (Weight, Body) 02/2013
1	Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy) 01/2013
1	Respiratory Insufficiency (Respiratory Failure) 09/2012
1	Muscle Hypotonia (Hypotonia) 09/2012
1	Muscular Diseases (Myopathy) 04/2012
1	Dementia (Dementias) 04/2012
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 04/2012
1	Aortic Aneurysm (Aneurysm, Aortic) 04/2012
1	Cataract (Cataracts) 01/2012
1	Hearing Loss (Hearing Impairment) 01/2012
1	Epilepsy (Aura) 10/2010
1	Seizures (Absence Seizure) 10/2010
1	Nervous System Diseases (Neurological Disorders) 09/2008
1	Aneurysm (Aneurysms) 09/2006
1	Emphysema 12/2005
1	Congenital Heart Defects (Congenital Heart Defect) 07/2004
1	Hemorrhage 07/2004
1	Thrombocytopenia (Thrombopenia) 07/2004
1	Anemia 02/2003
1	Strabismus (Squint) 08/2002
1	Myopia 08/2002
1	Hypopigmentation (Hypomelanosis) 08/2002

Drug/Important Bio-Agent (IBA)

37	CopperIBA 01/2022 - 01/2002
7	Copper-Transporting ATPasesIBA 01/2020 - 08/2009
6	P-type ATPasesIBA 05/2015 - 02/2003
5	Copper Transport ProteinsIBA 01/2020 - 10/2010
5	EnzymesIBA 11/2015 - 12/2005
3	MetalsIBA 01/2022 - 09/2008
3	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 04/2012 - 12/2005
2	Proteins (Proteins, Gene)FDA Link 01/2016 - 09/2008
2	Ceruloplasmin (Ferroxidase)IBA 01/2015 - 01/2012
2	Adenosine Triphosphatases (ATPase)IBA 02/2013 - 11/2006
2	Dopamine beta-HydroxylaseIBA 01/2013 - 08/2009
2	CatecholaminesIBA 01/2013 - 10/2010
2	Nonsense Codon (Nonsense Mutation)IBA 10/2010 - 01/2009
1	DNA (Deoxyribonucleic Acid)IBA 09/2020
1	Complement System Proteins (Complement)IBA 09/2020
1	Proteoglycans (Proteoglycan)IBA 12/2017
1	Tryptases (Tryptase)IBA 12/2017
1	Peptides (Polypeptides)IBA 01/2016
1	Messenger RNA (mRNA)IBA 01/2015
1	copper histidineIBA 10/2014
1	NucleotidesIBA 04/2014
1	SolutionsIBA 02/2013
1	Pharmaceutical PreparationsIBA 02/2013
1	Biomarkers (Surrogate Marker)IBA 01/2013
1	Biological ProductsIBA 01/2013
1	UbiquitinIBA 04/2012
1	Familial apoceruloplasmin deficiencyIBA 01/2012
1	catechol (pyrocatechol)IBA 08/2009
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 08/2009
1	3,4-dihydroxyphenylglycolIBA 08/2009
1	3,4-Dihydroxyphenylacetic AcidIBA 08/2009
1	Dopamine (Intropin)FDA LinkGeneric 08/2009
1	ElastinIBA 12/2005
1	Platelet Membrane GlycoproteinsIBA 07/2004
1	von Willebrand factor receptor (VWF receptor)IBA 07/2004
1	von Willebrand FactorIBA 07/2004
1	Mydriatics (Cycloplegics)IBA 08/2002
1	Retinaldehyde (Retinal)IBA 08/2002

Therapy/Procedure

1	Intraperitoneal Injections 02/2013
1	Injections 10/2010